Hamilton, ON, Canada and New York, NY – On October 3, 2023, Allarta Life Science, a Hamilton, Ontario-based regenerative medicine company announced it has received an award from JDRF International […]
Semaglutide, brand names Ozempic®, Rybelsus®, and Wegovy®, is all over the news. It is Health Canada-approved to help people with type 2 diabetes (T2D) manage their blood glucose levels. It […]
The JDRF Canada Emerging Clinician Research Award (ECRA) is designed to provide crucial support to investigators who plan to pursue a career in type 1 diabetes (T1D)-related clinical investigation. Awards […]
The following is a guest blog by Ryan MacDonald, volunteer co-chair of JDRF Canada’s $100M Campaign to Accelerate – JDRF’s bold fundraising campaign to raise $100M by 2025 to accelerate […]
50% of profits go to JDRF Warrior Hill was founded by a family with both a parent and child who live with type 1 diabetes (T1D) who have a passion […]
Content repurposed with permission from: type1better.com Despite best efforts to keep a child’s blood glucose within target, severe hypoglycemic episodes can happen, and it’s best to be prepared for the unpredictable. The […]
A significant part of JDRF Canada funding goes towards supporting cure-based research for type 1 diabetes (T1D). One such pathway is via stem cell replacement therapies that replace the beta […]
Throughout June more than 40 communities gathered across Canada to raise funds for type 1 diabetes research. The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising […]
A 2013-2016 JDRF-funded study showed that the use of a continuous glucose monitor (CGM) during pregnancy for people with type 1 diabetes (T1D) results in healthier pregnancies and babies. The […]
The American Diabetes Assocation’s 83rd Scientific Sessions were held from June 23- 26th. This annual conference brings together researchers and scientists to both present and learn about the latest in […]
What is Glucagon? Glucagon is a hormone that helps the liver release glucose to raise blood glucose levels. It can be administered through injection, auto-injection pen or nasal spray. Glucagon […]
JDRF Canada, in collaboration with CIHR, is thrilled to announce the recipients of the CIHR-JDRF Type 1 Diabetes Screening Research Consortium. This $12 million grant will develop a single nationally […]
